ARCHIVES

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

This article is from The Cancer Letter archive.

Vol. 16 No. 34 | September 7, 1990

Download PDF Visit The Full Archive

Related Articles

New Technology May Enable Therapy Tailored To Patient’s Predicted Response

April 26, 2002

Crout Resigns As Director Of FDA Drugs Bureau

July 11, 1980

Fifty-Nine CCOP Awards Made; Payline 250, Six Funded as Exceptions

May 27, 1983

Has To Plan International Meeting On Threat If DNA Biohazards

September 13, 1974

Cancer Act Pulled Entire NIH Budget Up, Schmidt Says

July 20, 1984

Letters: Subcommittee Report Full Of Errors, Gallo Attorney Says

February 3, 1995